Phase I Trial Of Temozolomide Combined With The Histone Deacetylase Inhibitor Valproic Acid (VPA) And Whole Brain Radiation Therapy (WBR) For Brain Metastases From Solid Tumors In Adults

Trial Profile

Phase I Trial Of Temozolomide Combined With The Histone Deacetylase Inhibitor Valproic Acid (VPA) And Whole Brain Radiation Therapy (WBR) For Brain Metastases From Solid Tumors In Adults

Discontinued
Phase of Trial: Phase I

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Temozolomide (Primary) ; Valproic acid (Primary)
  • Indications Cancer; Cancer metastases
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Feb 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 28 Jan 2009 Actual patient numbers (10) added as reported by ClinicalTrials.gov.
    • 28 Jan 2009 Planned end date (Sep 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top